United States - English - NLM (National Library of Medicine)

inventia healthcare private limited - duloxetine hydrochloride (unii: 9044sc542w) (duloxetine - unii:o5tnm5n07u) - duloxetine 20 mg - duloxetine is indicated for the treatment of: - major depressive disorder in adults - generalized anxiety disorder in adults - diabetic peripheral neuropathic pain in adults - fibromyalgia in adults and pediatric patients 13 years of age and older. - chronic musculoskeletal pain in adults additional pediatric use information is approved for eli lilly and company, inc.'s cymbalta (duloxetine) delayed-release capsules. however, due to eli lilly and company inc.'s marketing exclusivity rights, this drug product is not labeled with that pediatric information. monoamine oxidase inhibitors (maois) - the use of maois intended to treat psychiatric disorders with duloxetine or within 5 days of stopping treatment with duloxetine is contraindicated because of an increased risk of serotonin syndrome. the use of duloxetine within 14 days of stopping an maoi intended to treat psychiatric disorders is contraindicated [see dosage and administration (2.8) and warnings and precautions (5.4)] . starting duloxetine in a patient

United States - English - NLM (National Library of Medicine)

inventia healthcare private limited - metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - metformin hydrochloride 500 mg - metformin hydrochloride extended release tablets usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. metformin hydrochloride are contraindicated in patients with: - renal disease or renal dysfunction (e.g., as suggested by serum creatinine levels ≥1.5 mg/dl [males], ≥1.4 mg/dl [females] or abnormal creatinine clearance) which may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction, and septicemia (see warnings and precautions ). - known hypersensitivity to metformin hydrochloride. - acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. diabetic ketoacidosis should be treated with insulin. metformin hydrochloride should be temporarily discontinued in patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials, because use of such products may result in acute alteration of renal function. (see also precautions.

Australia - English - Department of Health (Therapeutic Goods Administration)

randox australia pty ltd - ct923 - multiple infectious organism ivds - the evidence investigator? sti multiplex detection array is a qualitative assay used for the simultaneous detection of 10 common viral and bacterial sexually transmitted infections from urine samples or urogenital swabs.

Kenya - English - Pharmacy and Poisons Board

inventia healthcare pvt. ltd. f1-f1/1 additional ambernath m.i.d.c. ambernath - aceclofenac bp (sustained release capsules 200 mg) - capsule - 200 mg - non-steroidal

Kenya - English - Pharmacy and Poisons Board

inventia healthcare pvt. ltd. f1-f1/1 additional ambernath m.i.d.c. ambernath - aceclofenac bp and thiocolchicoside ih (sustained… - capsule - aceclofenac 200 mg and thiocolchicoside 16 mg - non-steroidal

Kenya - English - Pharmacy and Poisons Board

inventia healthcare pvt. ltd. f1-f1/1 additional ambernath m.i.d.c. ambernath - aceclofenac bp and thiocolchicoside ih (sustained… - capsule - aceclofenac 200 mg and thiocolchicoside 8 mg - non-steroidal

Kenya - English - Pharmacy and Poisons Board

inventia healthcare pvt. ltd. f1-f1/1 additional ambernath m.i.d.c. ambernath - esomeprazole magnesium trihydrate usp… - capsule - 20 mg - drugs for peptic ulcer and gastro-oesophageal

Kenya - English - Pharmacy and Poisons Board

inventia healthcare pvt. ltd. f1-f1/1 additional ambernath m.i.d.c. ambernath - esomeprazole magnesium trihydrate usp… - capsule - 40 mg - drugs for peptic ulcer and gastro-oesophageal

Kenya - English - Pharmacy and Poisons Board

inventia healthcare pvt. ltd. f1-f1/1 additional ambernath m.i.d.c. ambernath - sildenafil citrate - inhouse (orodispersible… - chewable/dispersible tablet - 50 mg - drugs used inerectile dysfunction

Kenya - English - Pharmacy and Poisons Board

inventia healthcare pvt. ltd. f1-f1/1 additional ambernath m.i.d.c. ambernath - pregabalin - in house (sustained release tablets… - tablet - 150 mg/1500 mcg - other antiepileptics